Resonance Health Ltd has today signed a Patient Access to FerriSmart® Letter of Agreement with the World Health Organization related Cyprus based Thalassaemia International Federation (TIF).

Under the agreement, TIF will deploy 500 FerriSmart® vouchers, provided by Resonance Health at no cost, across targeted low-and-middle income countries in Asia, West Pacific, and Europe. Resonance Health will sponsor a dedicated TIF executive. The data collected from the FerriSmart® analysis will be used in TIF's Global Thalassaemia Review and by Resonance Health to improve and refine its product offerings.

To read the full article please click here.

Attachments

  • Original document
  • Permalink

Disclaimer

Resonance Health Limited published this content on 15 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 November 2021 08:29:03 UTC.